Additionally, the combo therapy led to greater reductions in abdominal fat and inflammation-related biomarkers, highlighting its potential as a more sustainable and health-optimized obesity treatment strategy
Diet and exercise Although GLP-1 Medication helps curb appetite, a balanced diet and regular physical activity will enhance results
Researchers believe this triple-hormone approach may explain why retatrutide appears to cause more weight loss than older drugs that target only one or two of these receptors
Traditional dieting requires constant willpower to resist hunger signals
The Initial Phase: Weeks 1-4 During the first several weeks on the lowest dose, most people notice a subtle reduction in appetite, feeling fuller sooner during meals, and less interest in snacking
Pregnancy, plans for pregnancy, breastfeeding, personal or family history of certain endocrine cancers, and other individual medical factors should be discussed before treatment